Literature DB >> 9428261

Indinavir in cerebrospinal fluid of HIV-1-infected patients.

L Ståhle, C Martin, J O Svensson, A Sönnerborg.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1997        PMID： 9428261     DOI： 10.1016/S0140-6736(05)63640-9

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  7 in total

1.  Diffusion tensor imaging of patients with HIV and normal-appearing white matter on MR images of the brain.

Authors:  C G Filippi; A M Ulug; E Ryan; S J Ferrando; W van Gorp
Journal:  AJNR Am J Neuroradiol       Date:  2001-02       Impact factor: 3.825

Review 2.  CSF penetration by antiretroviral drugs.

Authors:  Christine Eisfeld; Doris Reichelt; Stefan Evers; Ingo Husstedt
Journal:  CNS Drugs       Date:  2013-01       Impact factor: 5.749

Review 3.  The role of protease inhibitor therapy in children with HIV infection.

Authors:  Patrick J Gavin; Ram Yogev
Journal:  Paediatr Drugs       Date:  2002       Impact factor: 3.022

4.  Low atazanavir concentrations in cerebrospinal fluid.

Authors:  Brookie M Best; Scott L Letendre; Eileen Brigid; David B Clifford; Ann C Collier; Benjamin B Gelman; Justin C McArthur; J Allen McCutchan; David M Simpson; Ronald Ellis; Edmund V Capparelli; Igor Grant
Journal:  AIDS       Date:  2009-01-02       Impact factor: 4.177

Review 5.  Antiretroviral bioanalysis methods of tissues and body biofluids.

Authors:  Robin DiFrancesco; Getrude Maduke; Rutva Patel; Charlene R Taylor; Gene D Morse
Journal:  Bioanalysis       Date:  2013-02       Impact factor: 2.681

Review 6.  Clinical implications of CNS penetration of antiretroviral drugs.

Authors:  Heather E Wynn; Richard C Brundage; Courtney V Fletcher
Journal:  CNS Drugs       Date:  2002       Impact factor: 5.749

7.  Cerebrospinal fluid HIV-1 RNA, intrathecal immunoactivation, and drug concentrations after treatment with a combination of saquinavir, nelfinavir, and two nucleoside analogues: the M61022 study.

Authors:  Aylin Yilmaz; Dietmar Fuchs; Lars Hagberg; Ulrika Nillroth; Lars Ståhle; Jan-Olof Svensson; Magnus Gisslén
Journal:  BMC Infect Dis       Date:  2006-03-27       Impact factor: 3.090
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.